Just attended the presentation. Impressive technology.
key benefits
1: Impressive In Vivo results in mice
2: good survival rates over 90 days
3: the protection from reoccurrence without additional dosage 4: the off shelf treatment from healthy donors ( big advantage compared to using the cells taken from the patients which is faster, cheaper and potential of healthier cells being used instead of compromised cells from the affected patients).
5: patents to 2038
6: develop additional products using other CAR cells.
- Forums
- ASX - By Stock
- Ann: SUDA Licenses a Novel iNKT Cell Therapy Platform
Just attended the presentation. Impressive technology.key...
Featured News
Add ALA (ASX) to my watchlist
(20min delay)
|
|||||
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $168.2M |
Open | High | Low | Value | Volume |
16.0¢ | 16.5¢ | 15.5¢ | $140.9K | 877.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 345704 | 15.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 3094 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 345704 | 0.155 |
14 | 1097575 | 0.150 |
6 | 229940 | 0.145 |
5 | 169046 | 0.140 |
6 | 242000 | 0.135 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 3094 | 1 |
0.165 | 630509 | 8 |
0.170 | 725702 | 9 |
0.175 | 864999 | 8 |
0.180 | 1139230 | 6 |
Last trade - 15.21pm 27/09/2024 (20 minute delay) ? |
Featured News
ALA (ASX) Chart |